It has been suggested that, e.g., the nuclear matrix protein 22 (NMP22) BladderChek test may be used for the detection of bladder cancer; however, its sensitivity, specificity and diagnostic usefulness have not been unequivocally confirmed [17,18]. Here, NUMA1 is linked to urinary bladder carcinoma.